Health

Results: 253-264 of 8665

Avner Geva, Cofounder, CEO (left), and Avi Eftel, Cofounder, CTO (right)

Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder

World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical

The CTIONCOTEST™ platform by CTIBIOTECH is an innovative 3D bioprinting technology that revolutionizes preclinical cancer research . It provides an automated, industrial-scale process to produce high-throughput, patient-specific human "microtumors" directly from primary tumor cells . Designed to tackle the 95% clinical failure rate of new cancer drugs, it faithfully replicates the complex tumor microenvironment, including critical hypoxic and necrotic zones . Targeting high-mortality breast, colon, and pancreatic cancers, the platform features three complexity levels: standard (cancer cells), intermediate (+fibroblasts), and advanced (+immune/endothelial cells) . A key breakthrough is its record cellular viability of 128 days, enabling unprecedented long-term studies on drug resistance and metastasis . Ultimately, CTIONCOTEST delivers a highly predictive, 100% human-derived ethical alternative to animal testing.

Printing the Future of Oncology: CTIBIOTECH Invests €3M and Secures €1.25M from France 2030 to Revolutionize Personalized Cancer Care

New shares of Bioretec Ltd registered with the trade register

Masimo RD SET® Neo Pulse Oximetry Sensor

Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study

PR Newswire associated0

Echosens Appoints Romain Baujard as Group Chief Executive Officer

PR Newswire associated0

Bridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May 6-9, 2026

PR Newswire associated0

Alma Unveils Longevity Approach at Alma Academy, Advancing Long-Term Skin Performance

PR Newswire associated0

Natural Field Releases Research Findings on NFTriSolve® Co-Loading Liposome Technology

3Shape Receives FDA 510(k) Clearance for 3Shape Dx Software

Credits to Roquette

Roquette Showcases Its Expanded Consumer Healthcare Capabilities at Vitafoods Europe 2026

PR Newswire associated0

New guidance on surgical gloving to aid hand health of surgical teams and improve clinical outcomes